Recombinant erythropoietin, simultaneously with the action of ionizing radiation, led to the phenotypic conversion of non-stem cells into tumor-inducing breast cancer cells together with the re-expression of pluripotency factors c-Myc, Sox2, and Oct4 [23]. Here, EPO is linked to breast cancer.